Home › NDC Lookup › RxCUI directory › RxCUI 102787

Lincomycin 300 MG/ML Injectable Solution [Lincocin] — RxCUI 102787

Name: Lincomycin 300 MG/ML Injectable Solution [Lincocin] (RxCUI 102787)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 102787 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI102787

Official nameLincomycin 300 MG/ML Injectable Solution [Lincocin]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asLincocin 300 MG/ML Injectable Solution; Lincocin (as lincomycin HCl) 300 MG/ML Injectable Solution

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)455 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Lincomycin 300 MG/ML Injectable Solution [Lincoc... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Lincomycin 300 MG/ML Injectable Solution [Lincocin] RxCUI 102787 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Lincomycin 6398 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Lincocin 287531 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Lincomycin Injectable Solution 372606 SCDF
- Lincomycin Injectable Product 1164673 SCDG
- Lincomycin Injectable Solution [Lincocin] 362712 SBDF
- Lincocin Injectable Product 1177376 SBDG
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Lincomycin 300 MG/ML Injectable Solution 239212 SCD
- Lincomycin 300 MG/ML 329937 SCDC
- Lincomycin 300 MG/ML [Lincocin] 563136 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Lincomycin 300 MG/ML Injectable Solution SCD · 239212
Lincomycin 300 MG/ML SCDC · 329937
Lincomycin Injectable Solution SCDF · 372606
Lincomycin Injectable Product SCDG · 1164673

Brand-Name Concepts

Lincomycin 300 MG/ML [Lincocin] SBDC · 563136
Lincomycin Injectable Solution [Lincocin] SBDF · 362712
Lincocin Injectable Product SBDG · 1177376
Lincocin BN · 287531

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 102787 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00009-0104-04	1 VIAL in 1 CARTON (0009-0104-04) / 2 mL in 1 VIAL	Lincocin	Pharmacia & Upjohn Company LLC	2023-08-18
00009-0107-04	1 VIAL in 1 CARTON (0009-0107-04) / 10 mL in 1 VIAL	Lincocin	Pharmacia & Upjohn Company LLC	2023-04-18

Observed labelers: Pharmacia & Upjohn Company LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2010	Lincomycin injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.